Financials

  • Market Capitalization 7.4 M
  • Employee 14
  • Founded 1987
  • CEO N/A
  • Website www.soligenix.com
  • Headquarter Delaware, United States
  • FIGI BBG000FVMHG5
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.63
Rapporto prezzo/fatturato
-588.54

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4733
CURX
Curanex Pharmaceuticals Inc - Common Stock
4.88 USD-8.10%+1.88%+10.66%+674.60%7.65 M USD
4740
XCUR
Exicure, Inc. - Common Stock
1.14 USD+4.59%+4.59%-15.56%-77.56%7.46 M USD
4744
INM
InMed Pharmaceuticals Inc. - Common Shares
1.34 USD-1.47%+0.75%+3.88%-37.09%7.36 M USD
4754
LGVN
Longeveron Inc. - Class A Common stock
2.20 USD-10.20%-7.17%-70.11%+285.09%7.01 M USD

Notizie